Baijin Life Science Holdings (HKSE:01466) Cash per Share : HK$0.07 (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Baijin Life Science Holdings Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Baijin Life Science Holdings's Cash per Share for the quarter that ended in Sep. 2024 was HK$0.07.

Baijin Life Science Holdings Cash per Share Historical Data

The historical data trend for Baijin Life Science Holdings's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baijin Life Science Holdings Cash per Share Chart

Baijin Life Science Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash per Share

Get a 7-Day Free Trial

0.18

0.09

0.07

0.06

Baijin Life Science Holdings Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Cash per Share	Get a 7-Day Free Trial															0.03	0.07	0.06	0.06	0.07

Baijin Life Science Holdings Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Baijin Life Science Holdings's Cash per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	37.884	/	679.25
	=	0.06

Baijin Life Science Holdings's Cash per Share for the quarter that ended in Sep. 2024 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	44.37	/	679.25
	=	0.07

Baijin Life Science Holdings (HKSE:01466) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Baijin Life Science Holdings Cash per Share Related Terms

Thank you for viewing the detailed overview of Baijin Life Science Holdings's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Baijin Life Science Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Baijin Life Science Holdings Ltd (HKSE:01466) » Definitions » Cash per Share

Traded in Other Exchanges

MNNGF:USA

Address

66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG

Website

http://www.affluent-partners.com

Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.

Executives

Pacific Wish Limited
Chan Vincent Wing Sing
Hui Ka Man Emily
Ketto Inform Limited	2101 Beneficial owner
Su Yaoyao	2201 Interest of corporation controlled by you

Baijin Life Science Holdings Headlines

No Headlines